Results 271 to 280 of about 106,090 (294)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)

Chemical Society Reviews, 2019
Jiangjiexing Wu, Xiaoyu Wang, Yunyao Zhu
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Angiotensin-Converting Enzyme Inhibitors

2007
Alan H. Gradman, Darren Traub
openaire   +2 more sources

Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes

Chemical Society Reviews, 2013
Hui Wei, Erkang Wang
exaly  

Cellulosomes: plant-cell-wall-degrading enzyme complexes

Nature Reviews Microbiology, 2004
Akihiko Kosugi
exaly  

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

Enzyme immobilisation in biocatalysis: why, what and how

Chemical Society Reviews, 2013

exaly